Top Markets
Coin of the day
Rekah Pharmaceutical Industry Ltd. Rekah Pharmaceutical Industry Ltd.

Rekah Pharmaceutical Industry Ltd.

REKA
Rang in Aktien #39665
Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in... Rekah Pharmaceutical Industry Ltd., established in 1941 and headquartered in Holon, Israel, specializes in the production, marketing, distribution, and sale of a broad spectrum of healthcare items across Israel. The company's offerings include both prescription and over-the-counter medicines, dermo-cosmetic products, vitamins, and nutritional supplements. Its extensive portfolio comprises approximately 280 distinct pharmaceutical drugs used in various medical sectors. These encompass steroid tablets, antibiotics (such as penicillin and cephalosporin), eye drops and ointments for allergies, infections, and dryness, baby products, and dermatological treatments.
Aktienkurs
$3.40
Marktkapitalisierung
$388.12K
Veränderung (1 Tag)
-1.50%
Veränderung (1 Jahr)
-4.41%
Land
IL
Handel Rekah Pharmaceutical Industry Ltd. (REKA)

Kategorie

Dividendenrendite-Verlauf für Rekah Pharmaceutical Industry Ltd. (REKA)
Dividendenrendite (TTM) von Rekah Pharmaceutical Industry Ltd. (Aktienkürzel: REKA) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Rekah Pharmaceutical Industry Ltd. (REKA) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber